October 07, 2013
A New Jersey federal judge on Monday refused to dismiss claims against Sun Pharmaceuticals Ltd. in a patent suit over Sun's generic version of Cephalon Inc.'s anti-epilepsy drug, holding that Cephalon's complaint sufficiently claims willful infringement.
December 20, 2012
A New Jersey federal judge on Thursday declined to block sales of Sun Pharmaceutical Industries Ltd.'s generic version of Cephalon Inc.'s anti-epilepsy drug, saying Cephalon had failed to prove infringement and raising questions about its patent's validity.
February 10, 2012
A New Jersey federal judge on Thursday denied Cephalon Inc.'s request for a temporary restraining order blocking sales of Sun Pharmaceutical Industries Ltd.'s generic version of an anti-epilepsy drug, saying the Pennsylvania drugmaker's delay in bringing the patent infringement suit weighed against early judicial intervention.
September 22, 2011
Cephalon Inc. hit Sun Pharmaceutical Industries Inc. with a suit in New Jersey federal court Wednesday alleging its attempts to market a generic version of an anti-epilepsy drug infringed a Cephalon patent.